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The plasma membrane contains diverse and specialized membrane domains, which
include tetraspanin-enriched domains (TEMs) and transmembrane adaptor protein
(TRAP)-enriched domains. Recent biophysical, microscopic, and functional studies
indicated that TEMs and TRAP-enriched domains are involved in compartmentalization
of physicochemical events of such important processes as immunoreceptor signal
transduction and chemotaxis. Moreover, there is evidence of a cross-talk between TEMs
and TRAP-enriched domains. In this review we discuss the presence and function of
such domains and their crosstalk using mast cells as a model. The combined data based
on analysis of selected mast cell-expressed tetraspanins [cluster of differentiation (CD)9,
CD53, CD63, CD81, CD151)] or TRAPs [linker for activation of T cells (LAT), non-T cell
activation linker (NTAL), and phosphoprotein associated with glycosphingolipid-enriched
membrane microdomains (PAG)] using knockout mice or specific antibodies point to a
diversity within these two families and bring evidence of the important roles of these
molecules in signaling events. An example of this diversity is physical separation of
two TRAPs, LAT and NTAL, which are in many aspects similar but show plasma
membrane location in different microdomains in both non-activated and activated cells.
Although our understanding of TEMs and TRAP-enriched domains is far from complete,
pharmaceutical applications of the knowledge about these domains are under way.
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INTRODUCTION
The plasma membrane, as well as other cellular membranes, is a very complex structure composed
of a plethora of proteins and a variety of lipids organized into two asymmetrical leaflets. The proper
function of cellular membranes depends on the composition of the leaflets and intermolecular
communication of the membrane components. This is especially important in such complex
processes as signal transduction from plasma membrane receptors into the cytoplasm and nucleus.
Cellular membranes play a key role in signal transduction in both directions, inside-out and
outside-in. For years it has been thought that the lipid composition of the membrane allows
formation of signaling platforms that are critical for membrane functioning and that membrane
lipids and proteins play key roles as membrane organizers (Singer and Nicolson, 1972; van Meer
et al., 2008; Simons and Gerl, 2010; Treanor and Batista, 2010; Simons and Sampaio, 2011).
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Many systems have been used to study the structure-function
relationships of the plasma membrane components. Among
them are mast cells (MCs) or MC lines. MCs are effector cells
of the immune system that are able to react to external stimuli
by rapid release of numerous allergy mediators from cytoplasmic
granules and/or by production and secretion of a variety of
cytokines and chemokines. Activation of MCs is initiated by
binding of ligands [e.g., antigens (Ags)] to plasma membrane
receptors or their complexes [e.g., immunoglobulin (Ig)E bound
to high-affinity IgE receptor (FcεRI)]. This binding initiates cell
activation events, which involve a number of signal transduction
molecules forming functionally and spatially connected units,
called signalosomes. Receptor-mediated responses vary in
strength and duration. For example, aggregation of FcεRIs by
multimeric Ag-IgE complexes leads to phosphorylation of several
proteins, followed by Ca2+ response, in seconds after triggering,
release of pre-formed granules containing various mediators, in
minutes after activation, and ending by de novo synthesis of lipid
mediators, cytokines and chemokines in tens of minutes and
hours after activation (reviewed in Marshall, 2004; Galli et al.,
2008; Kalesnikoff and Galli, 2008; Galli and Tsai, 2012). These
signaling events could have dramatic physiological consequences,
such as causing allergy disease (Galli and Tsai, 2012) or breaking
down poison in snake venom (Metz et al., 2006), and therefore
must be precisely regulated (Galli, 2016). There are numerous
signal transduction regulators localized in the plasmamembrane,
membrane proximal, in the endoplasmic reticulum, as well as
in the cytoplasm. This review is focused on two groups of
transmembrane proteins that are involved in plasma membrane
receptor regulation and functioning. The first group consists
of tetraspanins, which span the plasma membrane four times
and form two extracellular domains and short intracellular tails.
The second group consists of transmembrane adaptor proteins
(TRAPs), which possess a short extracellular domain, one
transmembrane domain and a long intracellular tail with several
tyrosines that once phosphorylated can serve as anchor for
different proteins and in this way influence signal transduction.
Although these two groups of proteins are structurally different,
they share some common properties, such as palmitoylation and
ability to interact with a plethora of plasma membrane-bound
or intracellular proteins. Furthermore, recent studies with MCs
found a cross-talk between proteins in these two groups in the
regulation of plasma membrane-bound signaling events (Hálová
et al., 2013).
TETRASPANINS
Tetraspanins are an evolutionarily conserved superfamily of
transmembrane proteins with characteristic features. They have
four transmembrane domains and two extracellular loops, a small
one (SEL) and a large one (LEL). LEL possesses a conserved
CCG motif and at least two other cysteine residues that form
disulfide bonds inside the LEL domain (Figure 1). There are two
main post-translational modifications occurring in tetraspanins.
Most of them possess one or more N-glycosylation sites at
the LEL domain with two exceptions, cluster of differentiation
(CD)9, which possesses an N-glycosylation site in SEL, and
CD81, which is non-glycosylated (Boucheix and Rubinstein,
2001). Interestingly, all of the so far studied tetraspanins contain
a palmitoylation site (Charrin et al., 2002; Yang et al., 2002,
2004). Palmitoylation is a modification that tetraspanins share
with a plethora of other transmembrane or membrane-associated
proteins, such as TRAPs [including linker for activation of T
cells (LAT), non-T cell activation linker (NTAL; also called
LAT2), and phosphoprotein associated with glycosphingolipid-
enriched membrane microdomains (PAG; also called CSK-
binding proteins)] (Draber et al., 2011a; Stepanek et al., 2014),
integrins (Berditchevski, 2001; Gagnoux-Palacios et al., 2003;
Yang et al., 2004), SRC kinases (Kovárˇová et al., 2001; Gilfillan and
Rivera, 2009), and others. Examples of palmitoylated proteins
expressed on the MC membrane are presented in Figure 1.
Palmitoylation is important for the protein topography and its
functioning in the plasma membrane (see below).
Tetraspanins are known regulators of cell migration
(Boucheix and Rubinstein, 2001) and are involved in tumor
progression and metastasis (Zöller, 2009). Some tetraspanins
such as CD82, and often also CD9, are downregulated in
advanced stages of cancer; their absence is a sign of poor
prognosis in patients with several types of cancer. These
tetraspanins are considered as tumor suppressors. However,
some other tetraspanins, such as CD151 and TSPAN8, have
been found upregulated in metastases and their upregulation
was associated with poor prognosis, suggesting that they serve
as tumor promotors (reviewed in Zöller, 2009). The authors
speculated that the different roles of tetraspanins in tumor
progression could be the result of specific tetraspanin abundance
in exosomes. This could positively or negatively influence
the fusion of exosomes with plasma membranes in partner
cells, depending on the tetraspanin type. In this way exosomes
possessing different tetraspanins could exhibit different delivery
of important communicators such as mRNA and microRNA
and also proteins important in cell-cell communication (Zöller,
2009).
Several tetraspanins display broad tissue expression (e.g.,
CD9, CD81, CD151), whereas others are restricted e.g., to
leukocytes (CD37, CD53). Only a few tetraspanins (UP1a, UP1b,
peripherin and ROM-1) have their distribution limited to specific
tissue (Tarrant et al., 2003; Charrin et al., 2009, 2014). Although
tetraspanins are abundant proteins in many cell types, animals
deficient in selected tetraspanins usually do not exhibit striking
phenotypes, probably due to the redundancy and functional
compensation of individual tetraspanins. On the other hand,
mutations in individual tetraspanin genes have been described
as a cause of several life-threatening diseases (Kajiwara et al.,
1993, 1994; Zemni et al., 2000; Karamatic et al., 2004; van Zelm
et al., 2010). In some cases, mice lacking a particular tetraspanin
mimicked the phenotype observed in humans with a defect in the
same tetraspanin (Hemler, 2005).
Although several tetraspanins (CD9, CD37, CD53, CD63,
CD81, CD82, CD151) are abundantly expressed on the plasma
membrane of MCs and/or secretory vesicles (Table 1), their
role in MC physiology and activation events is not completely
understood. The problem is that for some tetraspanins there
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FIGURE 1 | Involvement of TEMs and TRAP-enriched domains in FcεRI signalosome. At the level of the plasma membrane, there is a cross-talk of FcεRI,
consisting of four transmembrane subunits (α,β, and γγ), with tetraspanins and TRAPs. These interactions affect FcεRI signal transduction. Phosphorylated ITAMs of
FcεRI bind LYN kinase, which is connected to the membrane by palmitoylation and myristoylation. Two important TRAPs, NTAL and LAT, which occupy different
nanodomains, are also palmitoylated. Tetraspanins are represented by CD9, which contains six palmitoylation domains and one possible glycosylation site in a small
intracellular loop, two disulfide bonds and tetraspanin conserved motif CCG are also depicted in the figure. Finally, integrins are represented by palmitoylated α4β1 that
is located in close proximity of CD9. The membrane is connected with the actin cytoskeleton through the FERM (4.1,ezrin/radixin/moesin) domain and actin-binding
domain (Abd) of ERM proteins. FERM binds directly to phosphatidylinositol 4 5-bisphosphate (PIP2).
are no commercially available antibodies and/or knockout (KO)
animals for such studies. The role of tetraspanins in MCs was
reviewed in 2012 (Köberle et al., 2012) and since then, several
new studies have appeared highlighting the significance of these
membrane organizers in MC physiology. The novel findings are
summarized below.
CD9
Although CD9 KO mice have been prepared (Le Naour et al.,
2000), they have not been used for the studies of the role of
CD9 in MC physiology. Thus, our knowledge about the role
of CD9 in MCs comes mainly from the studies using CD9-
specific antibodies. Our recent study described a new CD9-
specific monoclonal antibody (mAb), 2H9, which caused mast
cell degranulation, Ca2+ release and tyrosine phosphorylation of
several proteins including TRAP NTAL and dephosphorylation
of ezrin/radixin/moesin (ERM) family proteins (Hálová et al.,
2013). Phosphorylation of NTAL was brought about by complete
antibody but not its F(ab)2 fragment, suggesting that the Fc
fragment of the antibody is involved. Further studies showed that
2H9 antibody produced NTAL phosphorylation in cooperation
with FcγRs through SRC family kinase LYN, and that CD9 and
NTAL co-localized in the same membrane microdomains after
antibody-induced CD9 aggregation. A previous study showed
that antibody-induced aggregation of human CD9 expressed in
CD9-negative rat basophilic leukemia (RBL) cells, clone 2H3, also
caused degranulation, but its F(ab)2 fragment not (Higginbottom
et al., 2000). The authors speculated that CD9 and FcεRI form
complexes, and therefore crosslinking by anti-CD9 antibody
induced activation by a mechanism similar to the one induced by
aggregation of FcεRI. However, experiments with bone marrow-
derivedmast cells (BMMCs) showed that CD9 did not co-localize
with FcεRI in non-activated cells, but dimerization of CD9 with
bivalent antibody induced movement of CD9 into the close
proximity of FcεRI (Figure 2). This co-localization was further
strengthened by crosslinking of CD9-anti-CD9 complexes with
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TABLE 1 | Selected tetraspanins expressed in mast cells and their function.
Gene
symbol






Le Naour et al., 2000 Deficiency in sperm-egg fusion (Kaji et al., 2000; Le
Naour et al., 2000; Miyado et al., 2000; Wright et al.,
2004)/not studied
Antibodies against CD9 block MCs
migration toward IL-16 (Qi et al., 2006)
and Ag (Hálová et al., 2013) and
induce Ca2+ release and
phosphorylation of several substrates
(Hálová et al., 2013)
CD37 GP52-40, TSPAN26 Knobeloch et al., 2000 Mild alteration of immune system (Knobeloch et al.,
2000)/normal levels of IgE, MCs not particularly
studied (Knobeloch et al., 2000)
CD53 MOX44, Ox-44,
TSPAN25
Associated with population asthma
risk but not directly connected to MCs




Schröder et al., 2009 Mild defects, altered water balance (Schröder et al.,
2009)/reduced degranulation, TNF-α secretion, and
PCA (Kraft et al., 2013)
Antibody against CD63 suppresses




Maecker and Levy, 1997 Female infertility (Rubinstein et al., 2006), nervous
system malfunctions (Geisert et al., 2002), reduced
IL-4 production (Maecker et al., 1998), lower
expression of CD19 on B cells (Maecker and Levy,
1997)/not studied
Antibody against CD81 suppresses
degranulation and PCA (Fleming et al.,
1997)




Risinger et al., 2014 Mild changes in phenotype, could lead to changes in
early establishment of proliferation and division when





Wright et al., 2004; Sachs
et al., 2006
Bleeding (Wright et al., 2004), decreased
angiogenesis (Takeda et al., 2007), kidney failure
(Sachs et al., 2006)/increased late phase of PCA and
production of proinflammatory cytokines
(Abdala-Valencia et al., 2015)
CD151 is upregulated in MCs upon
FcεRI activation (Abdala-Valencia et al.,
2015)
secondary antibody (Hálová et al., 2013). Surprisingly, unlike
anti-CD63 (Kraft et al., 2005) or anti-CD81 (Fleming et al., 1997),
as discussed below, anti-CD9 did not modulate Ag-induced
degranulation (Hálová et al., 2013).
CD9 together with CD81 have been shown to co-localize
with a trimeric variant of FcεRI in human FcεRIpos dendritic
cells isolated from the skin of patients with atopic dermatitis.
In contrast, only moderate expression of CD9 and CD81 was
found on FcεRIneg monocytes (Peng et al., 2011). Concomitant
activation by FcεRI and CD9 crosslinking resulted in increased
interleukin (IL)-10 production compared to crosslinking of the
FcεRI alone. In contrast, co-activation of FcεRI with CD81 or
activation by aggregation of CD81 alone or CD9 alone had no
effect on IL-10 production (Peng et al., 1997). These data can
be taken as another evidence that CD9 and FcεRI are somehow
functionally cooperating.
Tetraspanins are well known regulators of chemotaxis and
migration in several cell types (Berditchevski, 2001; Boucheix and
Rubinstein, 2001). InMCs, IL-16 acts as a potent chemoattractant
(Qi et al., 2002). Surprisingly, chemotaxis of MCs toward IL-16
was blocked by anti-CD9 antibody or by reduced expression of
CD9 using RNA interference (RNAi) approach. These and other
findings led to the suggestion that CD9 acts as an alternate IL-
16 receptor (Qi et al., 2006). Studies with 2H9 anti-CD9 antibody
showed that intact IgG or its F(ab)2 fragment block chemotaxis of
MCs toward Ag, whereas Fab fragments had only minimal effects
on such chemotaxis. These findings suggest that inhibition of
chemotaxis toward Ag is caused by events induced by aggregation
of CD9 but does not require co-cross-linking of CD9 with FcγR.
Decreased expression of CD9 by lentiviral-induced RNAi CD9
knockdown (KD) did not affect migration toward Ag, suggesting
that CD9 is not involved in this process. However, the possibility
was not excluded that residual CD9 on the cell surface is involved
in the proper Ag-induced migration (Hálová et al., 2013).
CD63
CD63 was found to be located in the vicinity of FcεRI on RBL-
2H3 cells (Kitani et al., 1991). In MCs and basophils, CD63 is
expressed at the cell surface and at the membrane of secretory
lysosomes, including serotonin-containing granules that during
activation fuse with the plasma membrane. Therefore, CD63 is
extensively used as an activation marker of basophils. As the
response acts as “all-or-nothing” per cell, basophils either do
not bind the anti-CD63 mAb at all, or they bind a maximal
amount of the mAb, so that activated basophils can be easily
identified (Knol et al., 1991; Hoffmann et al., 2015). Unlike
basophils, a significant amount of CD63 is also expressed on
non-activated human MCs of different types, but similarly to
basophils it is also upregulated after activation (Valent et al.,
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FIGURE 2 | Topography of plasma membrane components in mast cells before and after activation with Ag or CD9-specific antibody. (A) In
non-activated cells, tetraspanin CD9 co-localizes with integrin in TEMs. These domains are topographically different from LAT- or NTAL-containing nanodomains, each
occupying a distinct plasma membrane region. FcεRI receptor is associated with LYN kinase in another membrane nanodomains. (B) Binding of Ag-specific IgE to
FcεRI, followed by exposure to multivalent Ag, causes multimerization of the FcεRI receptors. NTAL and LAT become phosphorylated, but are still separated in
different domains and do not co-localize with FcεRI and with each other. In contrast, antibody-mediated aggregation of CD9 brings CD9 into close proximity of NTAL
and FcγRs and causes NTAL phosphorylation. Activation through both FcεRI and CD9 leads to dephosphorylation of ERM and dynamic disconnection of the
membrane components and actin cytoskeleton. The conclusions indicated above are based on the interpretation of previously published data (Wilson et al., 2002;
Volná et al., 2004; Hálová et al., 2013).
2001). Recently, two structurally distinct isoforms of human
CD63 were identified, one characteristic of vesicles and another
expressed on the cell surface. Antibodies that differentiate
between these two isoforms are therefore prospective diagnostic
markers (Schäfer et al., 2010). Anti-CD63 mAb suppressed
degranulation of adherent (but not non-adherent) RBL-2H3
cells, whereas synthesis of leukotrienes (LTs) was not affected.
Initial stages of activation such as phosphorylation of signaling
proteins and Ca2+ responses were not inhibited by the antibody.
The ability of anti-CD63 mAb to suppress passive cutaneous
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anaphylaxis (PCA) in vivo makes CD63 a possible therapeutic
target (Kraft et al., 2005). As mice deficient in CD63 have been
recently prepared (Schröder et al., 2009), the role of CD63
for MC development and activation could be studied using
this model. Interestingly, although CD63 is highly expressed in
MCs, the number of MCs and their tissue distribution was not
altered in CD63 KO mice, and also MCs derived from bone
marrow of CD63 KO mice developed normally. When activated
with Ag, but not phorbol-12-myristate-13-acetate/ionomycin,
a significant decrease in FcεRI-mediated degranulation and
tumor necrosis factor (TNF)-α secretion was observed in CD63-
deficient BMMCs. On the other hand, secretion of IL-6 and LTC4
that are de novo synthetized upon activation was unaffected in
BMMCs with CD63 KO. This finding, together with the fact
that TNF-α is present in preformed granules, suggested that the
absence of CD63 in the secretory granules is the main cause of
reduced degranulation and TNF-α secretion (Kraft et al., 2013).
To test the role of CD63 in vivo, the authors introduced CD63
wild-type (WT) and KO MCs into mice of MC-deficient strain
Kitw/w−v and found out that mice reconstituted with CD63
KO MCs exhibited significantly decreased degranulation and
PCA. CD63-specific antibody, unlike CD9-specific antibody, was
unable to inhibit MC migration toward IL-16 (Qi et al., 2006).
CD81
Similarly to antibodies directed toward CD63 (see above),
mAb specific for CD81 was found to down-regulate FcεRI-
mediated degranulation in RBL-2H3 cells without affecting
initial tyrosine phosphorylation of signal-transduction proteins,
calcium response and synthesis of LTC4. The inhibitory effect of
anti-CD81 antibody was confirmed in vivo, where IgE-mediated
PCA in rats was significantly decreased (Fleming et al., 1997). On
the other hand, anti-CD81 antibody, unlike anti-CD9, was unable
to inhibit MC migration toward IL-16 (Qi et al., 2006).
Despite the fact that production of CD81 KO mice was
described almost 20 years ago (Maecker and Levy, 1997),
the role of CD81 in MC development or activation has not
been elucidated. A possible role of CD81 in MC activation
was suggested based on experiments in which allergen-induced
airway hyper-reactivity (AHR) was found to be diminished in
CD81 KO mice. These mice, in contrast to WT mice, once
challenged with ovalbumin (OVA) did not develop airway
inflammation characterized by the presence of inflammatory
cells, eosinophils, and synthesis of IL-4, IL-5, and IL-13 was
also dramatically reduced. On the other hand, the serum levels
of OVA-specific IgE were not changed (Deng et al., 2000). The
authors speculated that the reduced levels of cytokines could be
the reason of impaired MC activation in the absence of CD81
because anti-CD81 mAbs reduced MC activation. However, this
idea has never been proved.
CD151
Unlike other tetraspanins, CD151 was found to be upregulated
after activation of FcεRI in human and mouse MCs. Using
CD151 KO mice, Berdnikovs and colleagues studied the role of
CD151 in MC physiology (Abdala-Valencia et al., 2015). The
absence of CD151, did not lead to changes in degranulation
after Ag activation. On the other hand, mice with CD151 KO
exhibited a significant increase in magnitude of the late phase
of PCA response (24–36 h). In line with these findings, CD151-
deficient BMMCs showed enhanced production of several
proinflammatory cytokines, including IL-4, IL-13, and TNF-
α, which was probably related to the enhanced and sustained
FcεRI-induced extracellular signal-regulated kinase (ERK)1/2
and protein kinase B (PKB, also called AKT) phosphorylation in
these cells (Abdala-Valencia et al., 2015).
CD53
Although CD53 is expressed in MCs, there is only one study
showing association of CD53 with asthma risk via the functional
promoter polymorphism. Interestingly, siRNA-mediated KD of
CD53 in THP-1 human monocytic cells stimulated with house
dust mite led to increased production of inflammatory cytokines
as well as NFκB activity (Lee et al., 2013).
TRANSMEMBRANE ADAPTOR PROTEINS
Transmembrane adaptor proteins consist of a short extracellular
domain, a single transmembrane domain and a long cytoplasmic
tail. Extracellular domains are formed only by a few amino
acids, and are therefore unlikely to function as receptors for
extracellular ligands. The cytoplasmic tail possesses various
tyrosine-containing motifs that could act, after phosphorylation,
as scaffolds for anchor of multiple SRC homology (SH)2 domain-
containing cytoplasmic as well as membrane-associated proteins
and cytoskeletal components. As was already mentioned, most of
the TRAPs possess a juxtamembrane palmitoylation motif that
determines their solubility in non-ionic detergents, distribution
in the plasma membrane, and some functional properties. The
role of TRAPs in MC and leukocyte signaling has been recently
extensively reviewed (Draber et al., 2011a, 2016; Horejsi and
Hrdinka, 2014; Stepanek et al., 2014). Thus, this review is only
limited to a short description of some structural properties of
the most studied TRAPs in MCs that are important for the
membrane organization (Table 2).
LAT
The cytoplasmic tail of LAT contains nine highly conserved
tyrosine residues, of which five can be phosphorylated by spleen
tyrosine kinase (SYK) kinase upon activation and serve as
binding sites for SH2 domain-containing proteins including
growth factor receptor-bound protein 2 (GRB2), phospholipase
C (PLC)γ1, guanine nucleotide exchange factor VAV, ubiquitin
ligase CBL, SH2 domain-containing leukocyte protein of 76
kDa (SLP-76), and GRB2-related adaptor downstream of SHC
(GADS) (reviewed in Rivera, 2002, 2005; Draber et al., 2011a).
Although development of MCs was not affected in mice deficient
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TABLE 2 | Selected TRAPs expressed in mast cells and their function.
Gene
symbol
Most used aliases KO Phenotype of KO mice: general/in mast cells
LAT LAT1, pp36 Zhang et al., 1999 Defect in T-cell development—no mature T cells (Zhang et al., 1999)/reduced
degranulation, Ca2+ release and cytokine production, PSA (Saitoh et al., 2000)
LAT2 LAB, NTAL,
WBSCR15, WBSCR5
Volná et al., 2004; Zhu et al.,
2004
Increased levels of natural antibodies and humoral response (Wang et al., 2005)/increased
degranulation, Ca2+ release, cytokine production, PCA (Volná et al., 2004; Zhu et al.,
2004), and chemotaxis (Tumová et al., 2010)
PAG1 PAG, CBP Draberova et al., 2014 No visible changes in phenotype/reduced degranulation, Ca2+ release, cytokine
production, chemotaxis, PCA (Draberova et al., 2014)
LAX1 LAX Zhu et al., 2005a Reduction in CD23 expression on mature B cells, spontaneous germinal center formation,
hyper-responsiveness in T and B lymphocytes (Zhu et al., 2005a)/enhanced degranulation,
cytokine production, cell survival (Zhu et al., 2006)
GAPT Liu and Zhang, 2008 Increased B-cell proliferation and amount of Abs (Liu and Zhang, 2008)
in LAT (Saitoh et al., 2000), the mice exhibited reduced Ag-
mediated passive systemic anaphylaxis (PSA) responses. Ag-
stimulated BMMCs from LAT-deficient mice showed reduced
degranulation, Ca2+ release, and cytokine production (Saitoh
et al., 2000), whereas their chemotaxis was unchanged (Hálová
et al., 2013).
NTAL
NTAL shares several structural features with LAT, including
several tyrosine motifs of which five are the putative GRB2-
binding sites. However, there is nomajor homology in amino acid
sequences between these two adaptors and in contrast to LAT,
NTAL lacks the PLCγ1 binding motif. Similarly to LAT, NTAL
is rapidly phosphorylated upon Ag activation by SYK, and some
tyrosines are also phosphorylated by LYN. In contrast to LAT,
NTAL is also tyrosine phosphorylated upon c-KIT activation
by stem cell factor (SCF), LYN, and c-KIT itself (Iwaki et al.,
2008). Despite some similarities in features of LAT and NTAL
structures, BMMCs isolated from NTAL KO mice exhibited
increased degranulation, Ca2+ release, and cytokine production
(Volná et al., 2004; Zhu et al., 2004). Chemotaxis toward Ag
was also enhanced in NTAL-deficient cells (Tumová et al., 2010).
In accord with these observations, PCA of NTAL-KO mice was
also increased (Volná et al., 2004). Although it appeared that
LAT and NTAL act as opposite regulators of MC signaling, it
should be noted that the absence of both of them led to more
extensive inhibition of FcεRI-induced activation than the absence
of LAT alone (Volná et al., 2004; Zhu et al., 2004). Again, the
only exception was chemotaxis that was increased in double
KO cells compared to WT cells but still was lower than that in
NTAL-deficient cells (Hálová et al., 2013). These data indicate
that in the absence of NTAL, LAT acts as a negative regulator of
chemotaxis.
PAG
The structure of PAG is similar to that described for LAT
and NTAL, but in addition to 10 tyrosines, it possesses two
proline-rich domains that serve as binding sites for SH3 domains
and a C-terminal VTRL motif for interaction with the PDZ
domain of cytoskeletal linker ERM-binding protein of 50 kDa
(EBP50) (Brdicˇková et al., 2001). Upon FcεRI triggering, PAG is
phosphorylated by LYN in RBL-2H3 cells (Ohtake et al., 2002).
Phosphorylated tyrosine 317 (human) or 314 (mouse) is crucial
for binding of CSK. In RBL cells, overexpression of PAG led to
inhibition of receptor phosphorylation and subsequent decreased
degranulation (Ohtake et al., 2002). When BMMCs from mice
with PAG KO were analyzed, different findings were obtained.
PAG deficiency led to impaired Ag-induced degranulation,
extracellular Ca2+ uptake, tyrosine phosphorylation of several
proteins (including the FcεRI), production of cytokines and
chemokines, and also decreased chemotaxis (Draberova et al.,
2014). PAG-KO mice also exhibited impaired PCA. On the other
hand, activation through c-KIT led to increased degranulation,
suggesting different regulation of this TRAP after c-KIT and
FcεRI activation (Draberova et al., 2014).
LINKER FOR ACTIVATION OF X CELLS
(LAX)
LAX is another TRAP with multiple GRB2-binding motifs.
However, in contrast to LAT and NTAL, LAX has no
palmitoylation motif and is not localized in detergent-resistant
membranes (DRMs) (Zhu et al., 2002). LAX-deficient MCs
exhibited enhanced degranulation, enhanced activity of p38
mitogen-activated protein kinases (MAPK; PKB), and PI3K
activation after stimulation via FcεRI. Cytokine production and
cell survival were also enhanced in activated LAX-deficient cells.
On the other hand, the absence of LAX had no effect on calcium
response in vitro and PCA in vivo (Zhu et al., 2006).
GRB2-BINDING ADAPTOR PROTEIN,
TRANSMEMBRANE (GAPT)
GAPT has a short extracellular domain, a transmembrane
domain, and a cytoplasmic tail with multiple Grb2-binding
motifs. Similarly to LAX, GAPT does not reside in DRMs, even
though it contains potential palmitoylation sites similar to LAT
and NTAL. On the other hand, palmitoylation of GAPT has not
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been proved. In contrast to other mentioned TRAPs, GAPT is
not phosphorylated on tyrosine after FcεRI triggering (Liu and
Zhang, 2008).
MEMBRANE MICRO/NANO DOMAINS
OCCUPIED BY TETRASPANINS AND
TRAPS
Discovery of specific membrane domains came from the
studies of insoluble residues that remained after lysis of the
cells in buffers containing non-ionic detergents at 4◦C. These
DRMs formed predominantly by sphingolipids, cholesterol and
proteins, were proposed to play key roles inmembrane trafficking
and signaling (Simons and Ikonen, 1997). Studies of DRMs were
accelerated by development of the method of their isolation by
sucrose density gradient centrifugation of cells lysed in non-ionic
detergents. Both tetraspanins and palmitoylated TRAPs were
found to be associated with DRMs. The effect of palmitoylation
on the presence of these proteins in DRMs is discussed below.
Based on the differences in detergent sensitivity, TEMs, or
tetraspanin web, were identified as novel structures different from
glycosylphosphatidylinositol (GPI)-microdomains and caveolae.
It has been proposed that TEMs are involved in the plasma
membrane organization through tetraspanin-tetraspanin and
tetraspanin-other protein interaction (Boucheix and Rubinstein,
2001; Claas et al., 2001). In their sensitivity to different non-
ionic detergents, protein-protein and protein-lipid interactions
in TEMs differ from those in TRAP-enriched domains. Whereas
tetraspanin-tetraspanin interactions are preserved in nonionic
detergents Brij 58, Brij 97, Brij 98, and CHAPS, Triton X-
100 disrupts the majority of these interactions along with
participation of tetraspanins in sucrose low-density fractions.
On the other hand, lysis in Brij detergents at 37◦C disrupts
GPI-microdomains but not TEMs (Claas et al., 2001; Charrin
et al., 2003a, 2009). Tetraspanins were found to directly interact
with cholesterol (Charrin et al., 2003b). Furthermore, it has
been described that tetraspanins CD82 interacts with ganglioside
GM2 (Todeschini et al., 2007), tetraspanin CD9 binds to
GM3 (Kawakami et al., 2002) and that these interactions are
important for the association of these tetraspanins with integrins.
Since the concept of TEMs was proposed, most interactions of
tetraspanins with their partners (e.g., tetraspanins and integrins)
were identified by co-immunoprecipitation experiments after
lysis of the cells in mild detergents. Some of them were later
confirmed by crosslinking experiments or Förster resonance
transfer (FRET) analysis (Boucheix and Rubinstein, 2001).
The existence of specific membrane domains that are
dependent on lipid composition was at first deduced on the
basis of experiments with detergent solubility/insolubility of
individual membrane proteins and the term DRMs was coined.
Discovery and use of modern high-resolution techniques, such
as (FRET; McIntosh et al., 2012), fluorescence recovery after
photobleaching (FRAP; Axelrod et al., 1976), stimulated emission
depletion (STED; Auksorius et al., 2008), photoactivated
localization microscopy (PALM; Betzig et al., 2006), and
stochastic optical reconstruction microscopy (STORM; Rust
et al., 2006) contributed significantly to identifying the real
interactions on the plasma membrane components under in vivo
conditions. The first results obtained with the high-resolution
microscopic techniques (Kenworthy et al., 2000, 2004; Glebov
and Nichols, 2004) challenged the theories based on detergent
solubility. As more studies appeared, it was apparent that the
majority of the results are basically in accord with the existence of
plasma membrane domains, which are, however, of smaller size
than previously thought, and therefore the term nanodomains
was more often used for marking small dynamic domains that
vary in time and size and which are enriched in cholesterol and
sphingolipids.
Regarding tetraspanins, single-molecule fluorescence
microscopy of living cells revealed that tetraspanin assemblies
form dynamic interaction platforms in permanent exchange
with the rest of the membrane. Tracking of tetraspanin CD9
showed that most of the time it was undergoing Brownian
trajectories, but it was transiently trapped in platforms enriched
in CD9 and its partners. Both the mobility and partitioning in
the nanodomains were dependent on palmitoylation and plasma
membrane cholesterol (Espenel et al., 2008). FRET-FLIM analysis
revealed homophilic (CD9-CD9) and heterophilic (CD9-CD151)
tetraspanin interactions as well as their interaction with adhesion
molecules, with preferential association of CD9 with intercellular
adhesion molecule 1 (ICAM-1, also known as CD54) and of
CD151 with vascular cell adhesion molecule 1 (VCAM-1, also
known as CD106). FRAP analysis also revealed that a marker of
membranemicrodomains, rGPI-EGFP, diffusedmuch faster than
tetraspanins (Barreiro et al., 2008; Ley and Zhang, 2008). On the
other hand, recent work analyzed TEMs by STED microscopy
and showed that tetraspanins form individual nanoclusters. It
was also demonstrated that CD53 and CD37 domains showed
only minor overlap with clusters containing tetraspanins CD81
or CD82. It should be also noted that CD53 and CD81 reside
in closer proximity to their partners, major histocompatibility
complex (MHC) class II and CD19, respectively, than to other
tetraspanins (Zuidscherwoude et al., 2015).
When TRAPs were examined, using cells solubilized with
non-ionic detergents, LAT was found in DRMs (Zhang et al.,
1998). In contrast, FcεRI was not present in such domains
before activation, but once aggregated, FcεRI became associated
with DRMs. It has been suggested that association of FcεRI
with DRMs is a prerequisite for FcεRI activation because in
DRMs, FcεRI is phosphorylated by SRC family kinase LYN,
which is resident in DRMs (Field et al., 1995; Dráberová et al.,
2004). However, immunogold electron microscopy studies of
isolated plasma membrane sheets did not prove co-localization
of aggregated FcεRI and LAT, even though both domains were
increased in size (Wilson et al., 2001, 2002; Lebduška et al.,
2007). Scanning electron microscopy revealed that activation
of RBL cells with Ag causes redistribution of LAT in the
plasma membrane, where upon activation LAT was found in
bigger clusters than before activation (Veatch et al., 2012).
Although the studies did not examine whether LAT clusters
co-localize with FcεRI clusters the data clearly showed that
aggregation of FcεRIs causes redistribution of LAT. Recent
studies of LAT clustering in resting and activated T cells by
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PALM (Betzig et al., 2006) and direct STORM (Rust et al., 2006)
revealed that increase of LAT clusters after activation is due
to the translocation of LAT from subsynaptic vesicles to cell
surface and this recruitment is essential for LAT phosphorylation
(Williamson et al., 2011). In another study with single and two-
color PALM Sherman and collaborators showed that in resting
and activated T cells LAT primarily resides in nanoscale clusters
as small as dimers whose formation depended on protein-
protein and protein-lipid interactions (Sherman et al., 2011).
Furthermore, Lillemeier and collaborators used high-speed
version of photoactivated localization microscopy (hsPALM),
dual-color fluorescence cross-correlation spectroscopy (dsFCCS)
and transmission electron microscopy and showed that both the
T cell receptor (TCR) and LAT are preclustered into separate
and spatially separated membrane domains on quiescent cells.
After Ag recognition, these domains transiently concatenated
into microclusters without any substantial change in the size
and number of the component domains. These data suggest that
partitioning immunoreceptors and their downstream signaling
components into separate membrane domains, and then
bringing these domains together, may be an important and
general mechanism in the control of cell activation (Lillemeier
et al., 2016). In another study, analysis of LAT in the plasma
membrane of HeLa cells by fluorescence correlation spectroscopy
(FCS) and PALM showed that LAT diffusion is retarded and
its clustering in meso-scaled protein domains is decreased
when associating with ordered-lipid domains in contrast to
LAT associating with lipid-disordered domains (Owen et al.,
2012). Importance of cholesterol for formation of DRMs and for
immunoreceptor signaling has been repeatedly shown (Xavier
et al., 1998; Sheets et al., 1999; Surviladze et al., 2001). It
should also be noted that FcεRI-mediated activation is affected
by ethanol, which seems to interfere with proper function of
FcεRI-cholesterol signalosomes (Draberova et al., 2015) and
that phosphatase inhibitor, pervanadate, induces FcεRI β and
γ subunits tyrosine phosphorylation in the absence of FcεRI




Palmitoylation is a reversible lipid post-translational
modification of juxtamembrane cysteine residues, less frequently
also serine and threonine, in a variety of transmembrane or
membrane-associated proteins (Resh, 1999). Palmitoylation also
allows such modified proteins to float in the low-density fraction
of sucrose gradient after lysis in non-ionic detergents (Charrin
et al., 2002, 2009; Stepanek et al., 2014). However, loss of
palmitoylation of tetraspanins and TRAPs had a different impact
on their solubility in non-ionic detergents and interactions with
their partners. It has been shown that palmitoylation of CD151
had minimal influence on the density of tetraspanin-protein
complexes and did not promote tetraspanin localization into
DRMs or its association with α3β1 integrin, but its association
with other cell surface proteins, including CD9 and CD63,
was reduced (Yang et al., 2002). The palmitoylation of CD9
did not influence its localization into DRMs but was necessary
for its interaction with other tetraspanins, namely CD81
and CD53 (Charrin et al., 2002). Similar observations were
obtained when membrane compartmentalization of integrins
had been studied. It has been suggested that palmitoylation of
β4 promotes its association with DRMs and SRC family kinases
(Gagnoux-Palacios et al., 2003) but further studies showed that
β4 palmitoylation does not increase its localization into DRMs,
instead it promotes CD151–α6β4 incorporation into a network
of secondary tetraspanin interactions (Yang et al., 2004).
Although importance of palmitoylation for proper function
of TRAPs has been shown, it still remains in part controversial.
LAT is palmitoylated at C26 and C29 and this event is crucial
for LAT association with DRMs and proper immunoreceptor
function (Zhang et al., 1998; Levental et al., 2010). An important
question was whether palmitoylation is also important for plasma
membrane localization. It has been reported that the LAT
mutated in the cysteines separately or together was localized into
the plasmamembrane of HEK cells (Zhang et al., 1998). However
in this study LAT was not examined for its co-localization
with plasma membrane markers. Recent studies showed that
palmitoylation at C26 is essential for transporting of LAT from
Golgi to plasma membrane (Hundt et al., 2009; Chum et al.,
2016). In contrast, surprisingly, NTAL and PAG did not require
palmitoylation for plasma membrane localization (Chum et al.,
2016).
In another study, mutant LAT was constructed, in
which transmembrane domain of LAT was exchanged with
transmembrane domain of LAX, another TRAP, that lacks
palmitoylation motifs, but possesses LAX transmembrane
signal peptide that provides localization of the LAX in plasma
membrane. This LAX-LAT protein was not detected in DRMs
but appeared to be fully functional in T cell activation and
development (Zhu et al., 2005b). Similar results were obtained
when SRC-LAT mutant was constructed and examined in
similar assays. The mutant protein was localized as peripheral
membrane protein through myristoylation of its SRC domain
but it was excluded from DRMs and appeared to be fully
functional in TCR signaling (Hundt et al., 2009). Later studies
of LAX-LAT mutant protein showed that it is localized in an
atypical DRMs—called “heavy” DRMs (Otáhal et al., 2010).
When CD25-LAT mutant was used, it was excluded from both
DRMs and “heavy” DRMs (Otáhal et al., 2010). This study also
demonstrated that the level of exogenous construct expression
is critical for proper interpretation of the results. At the levels of
expression, corresponding to the expression level of endogenous
LAT, WT LAT, present mostly in DRMs, supported signaling
better than LAX–LAT mutant; the CD25-LAT mutant was the
least effective in the assay (Otáhal et al., 2010). Importance of
palmitoylation for association with DRMs was also shown in
studies with mutant LYN kinase in RBL cells. LYN mutated in
both palmitoylation and myristoylation sites, did not anchor to
the plasma membrane, whereas LYN with only palmitoylation
site mutated was anchored to the plasma membrane, but its
localization into DRMs was markedly reduced (Kovárová
et al., 2001). Interestingly, studies with RBL cells showed that
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clustering of FcεRI led to co-clustering with LYN, depending on
the presence of cholesterol (Veatch et al., 2012). Furthermore,
FcεRI motility in the plasma membrane after Ag triggering was
also dependent on cholesterol levels (Shelby et al., 2013).
TETRASPANINS AND TRAPS CROSS-TALK
Electron microscopy studies showed that LAT and NTAL,
despite their structural similarities and proved association with
DRMs, occupy separate membrane microdomains in MCs
(Volná et al., 2004). The differences between the LAT and
NTAL microdomains were confirmed in experiments in which
topography of CD9 and TRAPs in the plasma membrane was
examined: while NTAL co-localized with CD9, LAT did not
(Hálová et al., 2013). CD9-NTAL co-localization was intensified
by crosslinking CD9 with specific mAb, and this crosslinking
resulted in enhanced phosphorylation of NTAL (Hálová et al.,
2013). There are other examples of interaction between TRAPs
and tetraspanins. Two recently identified TRAPs, SLP65/SLP76,
Csk-interacting membrane protein (SCIMP) and leukocyte-
specific transcript 1/A (LST1/A) were found to interact with
tetraspanins (Draber et al., 2011b, 2012). SCIMP, which is
expressed in B cells and other professional Ag-presenting cells,
co-localized with tetraspanins CD81 and CD37 (Draber et al.,
2011b), whereas LST1/A, which is expressed exclusively in
the cells of myeloid origin (monocytes and granulocytes), co-
localized with tetraspanins CD9 and CD81 (Draber et al., 2012).
Both tetraspanins and TRAPs were found to function
as direct or indirect linkers of the plasma membrane and
cytoskeleton. Co-immunoprecipitation studies showed that
tetraspanins CD9 and CD81 are associated with ERM proteins,
which directly interact with the cytoskeleton (Sala-Valdés et al.,
2006). ERM proteins link plasma membrane phospholipids by
binding their N-terminal FERM (4.1, ezrin/radixin/moesin)
domain to phosphatidylinositol (4,5) bisphosphate (PIP2)
and the actin cytoskeleton through the actin-binding
domain (Abd) at the C-terminus. This binding is a highly
dynamic process dependent on ERM 567/564/558 threonine
phosphorylation/dephosphorylation. ERMs are released from the
membrane when their inhibitory threonine is dephosporylated
and ERMs are transformed from “open” phosphorylated
to “closed” dephosphorylated conformation (McClatchey,
2014). However, it has not been clarified whether interactions
between tetraspanins and ERMs are direct or indirect through
tetraspanin-interacting proteins CD9P-1 and/or EWI-2 (Sala-
Valdés et al., 2006). Earlier studies showed that engaging CD81
at the surface of B cells led to phosphorylation of ezrin by
the SYK kinase (Coffey et al., 2009). In MCs, crosslinking of
CD9 with mAb led to dephosphorylation of ERM inhibitory
threonine (Hálová et al., 2013). TRAP PAG also interacts with
ezrin, but in this case through ERM-binding phosphoprotein of
50 kDa (EBP50). In this binding, the N-terminal PDZ domain of
EBP50 and C-terminal domain of PAG are involved (Brdicˇková
et al., 2001). The ezrin-EBP50-PAG complex was found to be
important for the spatio-temporal control of cAMP production
through the CSK-PAG inhibitory pathway in effector T cells
(Cornez and Taskén, 2010).
CONCLUDING REMARKS AND
PERSPECTIVES
Although knowledge about tetraspanins and TRAPs at the
level of proteins and the corresponding genes and their
regulators is increasing, their functioning as platforms of
plasma membrane signalosomes and their mutual crosstalk
are far from understood. The exact composition of TEMs
and TRAPs-enriched domains is also poorly defined. This
is in part due to highly dynamic nature of the membrane
domains and the large number of various lipids involved.
Lipids function not only as a matrix in which tetraspanins,
TRAPs, and other membrane proteins are anchored, but also
as modifiers of various proteins. When focusing specifically on
signal transduction in MCs, there are also many poorly explored
areas, which include potential roles of various post-translational
modifications on topography and function of the tetraspanins
and TRAPs and their interaction partners. An important area
to explore is the role of miRNAs, noncoding RNAs, and other
regulators of tetraspanins and TRAPs expression (Zhang et al.,
2014; Rouquette-Jazdanian et al., 2015). As shown in this
review focused on MCs, important discoveries concerning the
role of individual members of tetraspanins and TRAPs were
brought by studies based on cells deficient in selected proteins
through the gene KO or KD approach. However, with the
armamentarium of proteomics, lipidomics, epigenetics, super-
resolution microscopy, multi-photon microscopy, etc., our pace
of discoveries in the field of specific membrane nanodomains
will be accelerated in the next few years. Most of the studies
mentioned in this review were performed using cells cultured
under in vitro conditions. However, one needs to understand
more on how TEMs and TRAPs-enriched domains function
under in vivo conditions. This issue involves not only the
influence of various soluble factors that are absent in cell
culture media, but also the interaction with other cells and
extracellular matrix components that could influence functions
of the tetraspanins and their interaction partners. Such type of
studies in the case of MCs will deepen our understanding
of the cellular and molecular mechanisms underlying allergic
diseases.
AUTHOR CONTRIBUTIONS
Both authors have made substantial, direct and intellectual
contribution to the work, and approved it for publication.
ACKNOWLEDGMENTS
This study was supported by projects 14-09807S and 14-00703S
from the Czech Science Foundation and by the Institute of
Molecular Genetics of the Acad. Sci. Czech Republic (RVO
68378050).
Frontiers in Cell and Developmental Biology | www.frontiersin.org 10 May 2016 | Volume 4 | Article 43
Halova and Draber Tetraspanins/TRAPs As Plasma Membrane Organizers
REFERENCES
Abdala-Valencia, H., Bryce, P. J., Schleimer, R. P., Wechsler, J. B., Loffredo, L.
F., Cook-Mills, J. M., et al. (2015). Tetraspanin CD151 is a negative regulator
of FcεRI-mediated mast cell activation. J. Immunol. 195, 1377–1387. doi:
10.4049/jimmunol.1302874
Auksorius, E., Boruah, B. R., Dunsby, C., Lanigan, P. M., Kennedy, G., Neil,
M. A., et al. (2008). Stimulated emission depletion microscopy with a
supercontinuum source and fluorescence lifetime imaging. Opt. Lett. 33,
113–115. doi: 10.1364/OL.33.000113
Axelrod, D., Koppel, D. E., Schlessinger, J., Elson, E., and Webb, W. W. (1976).
Mobility measurement by analysis of fluorescence photobleaching recovery
kinetics. Biophys. J. 16, 1055–1069. doi: 10.1016/S0006-3495(76)85755-4
Barreiro, O., Zamai, M., Yáñez-Mó, M., Tejera, E., López-Romero, P., Monk,
P. N., et al. (2008). Endothelial adhesion receptors are recruited to adherent
leukocytes by inclusion in preformed tetraspanin nanoplatforms. J. Cell Biol.
183, 527–542. doi: 10.1083/jcb.200805076
Berditchevski, F. (2001). Complexes of tetraspanins with integrins: more than
meets the eye. J. Cell Sci. 114, 4143–4151.
Betzig, E., Patterson, G. H., Sougrat, R., Lindwasser, O. W., Olenych, S.,
Bonifacino, J. S., et al. (2006). Imaging intracellular fluorescent proteins
at nanometer resolution. Science 295, 1642–1645. doi: 10.1126/science.11
27344
Boucheix, C., and Rubinstein, E. (2001). Tetraspanins. Cell Mol. Life Sci. 58,
1189–1205. doi: 10.1007/PL00000933
Brdicˇková, N., Brdicˇka, T., Andeˇra, L., Špicˇka, J., Angelisová, P., Milgram, S. L et al.
(2001). Interaction between two adapter proteins, PAG and EBP50: a possible
link between membrane rafts and actin cytoskeleton. FEBS Lett. 507, 133–136.
doi: 10.1016/S0014-5793(01)02955-6
Charrin, S., Jouannet, S., Boucheix, C., and Rubinstein, E. (2014). Tetraspanins at
a glance. J. Cell Sci. 127, 3641–3648. doi: 10.1242/jcs.154906
Charrin, S., Le Naour, F., Silvie, O., Milhiet, P. E., Boucheix, C., and Rubinstein, E.
(2009). Lateral organization of membrane proteins: tetraspanins spin their web.
Biochem. J. 420, 133–154. doi: 10.1042/BJ20082422
Charrin, S., Manié, S., Billard, M., Ashman, L., Gerlier, D., Boucheix, C., et al.
(2003a). Multiple levels of interactions within the tetraspanin web. Biochem.
Biophys. Res. Commun. 304, 107–112. doi: 10.1016/S0006-291X(03)00545-X
Charrin, S., Manié, S., Oualid, M., Billard, M., Boucheix, C., and Rubinstein,
E. (2002). Differential stability of tetraspanin/tetraspanin interactions: role of
palmitoylation. FEBS Lett. 516, 139–144. doi: 10.1016/S0014-5793(02)02522-X
Charrin, S., Manié, S., Thiele, C., Billard, M., Gerlier, D., Boucheix, C., et al.
(2003b). A physical and functional link between cholesterol and tetraspanins.
Eur. J. Immunol. 33, 2479–2489. doi: 10.1002/eji.200323884
Chum, T., Glatzová, D., Kvícˇalová, Z., Malínský, J., Brdicˇka, T., and Cebecauer,
M. (2016). The role of palmitoylation and transmembrane domain in
sorting of transmembrane adaptor proteins. J. Cell Sci. 129, 95–107. doi:
10.1242/jcs.175190
Claas, C., Stipp, C. S., and Hemler, M. E. (2001). Evaluation of prototype
transmembrane 4 superfamily protein complexes and their relation to lipid
rafts. J. Biol. Chem. 276, 7974–7984. doi: 10.1074/jbc.M008650200
Coffey, G. P., Rajapaksa, R., Liu, R., Sharpe, O., Kuo, C. C., Krauss, S. W., et al.
(2009). Engagement of CD81 induces ezrin tyrosine phosphorylation and its
cellular redistribution with filamentous actin. J. Cell Sci. 122, 3137–3144. doi:
10.1242/jcs.045658
Cornez, I., and Taskén, K. (2010). Spatiotemporal control of cyclic AMP
immunomodulation through the PKA-Csk inhibitory pathway is achieved by
anchoring to an Ezrin-EBP50-PAG scaffold in effector T cells. FEBS Lett. 584,
2681–2688. doi: 10.1016/j.febslet.2010.04.056
Deng, J., Yeung, V. P., Tsitoura, D., Dekruyff, R. H., Umetsu, D. T., and Levy,
S. (2000). Allergen-induced airway hyperreactivity is diminished in CD81-
deficient mice. J. Immunol. 165, 5054–5061. doi: 10.4049/jimmunol.165.9.5054
Draberova, L., Bugajev, V., Potuckova, L., Halova, I., Bambouskova, M.,
Polakovicova, I., et al. (2014). Transmembrane adaptor protein PAG/CBP is
involved in both positive and negative regulation of mast cell signaling. Mol.
Cell Biol. 34, 4285–4300. doi: 10.1128/MCB.00983-14
Dráberová, L., Lebduška, P., Hálová, I., Tolar, P., Štokrová, J., Tolarová, H., et al.
(2004). Signaling assemblies formed in mast cells activated via Fcε receptor I
dimers. Eur. J. Immunol. 34, 2209–2219. doi: 10.1002/eji.200322663
Draber, P., Halova, I., Levi-Schaffer, F., andDraberova, L. (2011a). Transmembrane
adaptor proteins in the high-affinity IgE receptor signaling. Front. Immunol.
2:95. doi: 10.3389/fimmu.2011.00095
Draber, P., Halova, I., Polakovicova, I., and Kawakami, T. (2016). Signal
transduction and chemotaxis in mast cells. Eur. J. Pharmacol. 778, 11–23. doi:
10.1016/j.ejphar.2015.02.057
Draber, P., Stepanek, O., Hrdinka, M., Drobek, A., Chmatal, L., Mala, L., et al.
(2012). LST1/A is a myeloid leukocyte-specific transmembrane adaptor protein
recruiting protein tyrosine phosphatases SHP-1 and SHP-2 to the plasma
membrane. J. Biol. Chem. 287, 22812–22821. doi: 10.1074/jbc.M112.339143
Draber, P., Vonkova, I., Stepanek, O., Hrdinka, M., Kucova, M., Skopcova, T.,
et al. (2011b). SCIMP, a transmembrane adaptor protein involved in major
histocompatibility complex class II signaling.Mol. Cell Biol. 31, 4550–4562. doi:
10.1128/MCB.05817-11
Draberova, L., Paulenda, T., Halova, I., Potuckova, L., Bugajev, V., Bambouskova,
M., et al. (2015). Ethanol inhibits high-affinity immunoglobulin E receptor
(FcεRI) signaling in mast cells by suppressing the function of FcεRI-
cholesterol signalosome. PLoS ONE 10:e0144596. doi: 10.1371/journal.pone.01
44596
Espenel, C., Margeat, E., Dosset, P., Arduise, C., Le, G. C., Royer, C. A., et al. (2008).
Single-molecule analysis of CD9 dynamics and partitioning reveals multiple
modes of interaction in the tetraspanin web. J. Cell Biol. 182, 765–776. doi:
10.1083/jcb.200803010
Field, K. A., Holowka, D., and Baird, B. (1995). FcεRI-mediated recruitment
of p53/56lyn to detergent-resistant membrane domains accompanies
cellular signaling. Proc. Natl. Acad. Sci. U.S.A. 92, 9201–9205. doi:
10.1073/pnas.92.20.9201
Fleming, T. J., Donnadieu, E., Song, C. H., Laethem, F. V., Galli, S. J., and Kinet,
J. P. (1997). Negative regulation of FcεRI-mediated degranulation by CD81. J.
Exp. Med. 186, 1307–1314. doi: 10.1084/jem.186.8.1307
Gagnoux-Palacios, L., Dans, M., van’t Hof, W., Mariotti, A., Pepe, A., Meneguzzi,
G., et al. (2003). Compartmentalization of integrin α6β4 signaling in lipid rafts.
J. Cell Biol. 162, 1189–1196. doi: 10.1083/jcb.200305006
Galli, S. J. (2016). The mast cell-ige paradox: from homeostasis to anaphylaxis.Am.
J. Pathol. 186, 212–224. doi: 10.1016/j.ajpath.2015.07.025
Galli, S. J., Grimbaldeston, M., and Tsai, M. (2008). Immunomodulatory mast cells:
negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 8,
478–486. doi: 10.1038/nri2327
Galli, S. J., and Tsai, M. (2012). IgE and mast cells in allergic disease. Nat. Med. 18,
693–704. doi: 10.1038/nm.2755
Geisert, E. E. Jr., Williams, R.W., Geisert, G. R., Fan, L., Asbury, A.M., Maecker, H.
T., et al. (2002). Increased brain size and glial cell number in CD81-null mice.
J. Comp. Neurol. 453, 22–32. doi: 10.1002/cne.10364
Gilfillan, A. M., and Rivera, J. (2009). The tyrosine kinase network regulating
mast cell activation. Immunol. Rev. 228, 149–169. doi: 10.1111/j.1600-
065X.2008.00742.x
Glebov, O. O., and Nichols, B. J. (2004). Lipid raft proteins have a random
distribution during localized activation of the T-cell receptor. Nat. Cell Biol.
6, 238–243. doi: 10.1038/ncb1103
Hálová, I., Dráberová, L., Bambousková, M., Machyna, M., Stegurová, L., Smrž,
D., et al. (2013). Cross-talk between tetraspanin CD9 and transmembrane
adaptor protein non-T cell activation linker (NTAL) in mast cell activation and
chemotaxis. J. Biol. Chem. 288, 9801–9814. doi: 10.1074/jbc.M112.449231
Hemler, M. E. (2005). Tetraspanin functions and associated microdomains. Nat.
Rev. Mol. Cell Biol. 6, 801–811. doi: 10.1038/nrm1736
Heneberg, P., Dráberová, L., Bambousková, M., Pompach, P., and Dráber, P.
(2010). Down-regulation of protein tyrosine phosphatases activates an immune
receptor in the absence of its translocation into lipid rafts. J. Biol. Chem. 285,
12787–12802. doi: 10.1074/jbc.M109.052555
Higginbottom, A., Wilkinson, I., McCullough, B., Lanza, F., Azorsa, D. O.,
Partridge, L. J., et al. (2000). Antibody cross-linking of human CD9 and the
high-affinity immunoglobulin E receptor stimulates secretion from transfected
rat basophilic leukaemia cells. Immunology 99, 546–552. doi: 10.1046/j.1365-
2567.2000.00992.x
Hoffmann, H. J., Santos, A. F., Mayorga, C., Nopp, A., Eberlein, B., Ferrer, M.,
et al. (2015). The clinical utility of basophil activation testing in diagnosis
and monitoring of allergic disease. Allergy 70, 1393–1405. doi: 10.1111/all.
12698
Frontiers in Cell and Developmental Biology | www.frontiersin.org 11 May 2016 | Volume 4 | Article 43
Halova and Draber Tetraspanins/TRAPs As Plasma Membrane Organizers
Horejsi, V., and Hrdinka, M. (2014). Membrane microdomains
in immunoreceptor signaling. FEBS Lett. 588, 2392–2397. doi:
10.1016/j.febslet.2014.05.047
Hundt, M., Harada, Y., De Giorgio, L., Tanimura, N., Zhang, W., and Altman, A.
(2009). Palmitoylation-dependent plasma membrane transport but lipid raft-
independent signaling by linker for activation of T cells. J. Immunol. 183,
1685–1694. doi: 10.4049/jimmunol.0803921
Iwaki, S., Spicka, J., Tkaczyk, C., Jensen, B. M., Furumoto, Y., Charles,
N., et al. (2008). Kit- and FcεRI-induced differential phosphorylation of
the transmembrane adaptor molecule NTAL/LAB/LAT2 allows flexibility
in its scaffolding function in mast cells. Cell Signal. 20, 195–205. doi:
10.1016/j.cellsig.2007.10.013
Kaji, K., Oda, S., Shikano, T., Ohnuki, T., Uematsu, Y., Sakagami, J., et al. (2000).
The gamete fusion process is defective in eggs of CD9-deficient mice. Nat.
Genet. 24, 279–282. doi: 10.1038/73502
Kajiwara, K., Berson, E. L., and Dryja, T. P. (1994). Digenic retinitis pigmentosa
due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science 264,
1604–1608. doi: 10.1126/science.8202715
Kajiwara, K., Sandberg, M. A., Berson, E. L., and Dryja, T. P. (1993).
A null mutation in the human peripherin/RDS gene in a family with
autosomal dominant retinitis punctata albescens. Nat. Genet. 3, 208–212. doi:
10.1038/ng0393-208
Kalesnikoff, J., and Galli, S. J. (2008). New developments in mast cell biology. Nat.
Immunol. 9, 1215–1223. doi: 10.1038/ni.f.216
Karamatic, C. V., Burton, N., Kagan, A., Green, C. A., Levene, C.,Anstee, D. J., et al.
(2004). CD151, the first member of the tetraspanin (TM4) superfamily detected
on erythrocytes, is essential for the correct assembly of human basement
membranes in kidney and skin. Blood 104, 2217–2223. doi: 10.1182/blood-
2004-04-1512
Kawakami, Y., Kawakami, K., Steelant, W. F., Ono, M., Baek, R. C., Handa, K.,
et al. (2002). Tetraspanin CD9 is a “proteolipid, ” and its interaction with α3
integrin inmicrodomain is promoted byGM3 ganglioside, leading to inhibition
of laminin-5-dependent cell motility. J. Biol. Chem. 277, 34349–34358. doi:
10.1074/jbc.M200771200
Kenworthy, A. K., Nichols, B. J., Remmert, C. L., Hendrix, G. M., Kumar, M.,
Zimmerberg, J., et al. (2004). Dynamics of putative raft-associated proteins at
the cell surface. J. Cell Biol. 165, 735–746. doi: 10.1083/jcb.200312170
Kenworthy, A. K., Petranova, N., and Edidin, M. (2000). High-resolution FRET
microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell
plasma membranes.Mol. Biol. Cell 11, 1645–1655. doi: 10.1091/mbc.11.5.1645
Kitani, S., Berenstein, E., Mergenhagen, S., Tempst, P., and Siraganian, R. P. (1991).
A cell surface glycoprotein of rat basophilic leukemia cells close to the high
affinity IgE receptor (FcεRI). Similarity to human melanoma differentiation
antigen ME491. J. Biol. Chem. 266, 1903–1909.
Knobeloch, K. P., Wright, M. D., Ochsenbein, A. F., Liesenfeld, O., Löhler, J.,
Zinkernagel, R. M., et al. (2000). Targeted inactivation of the tetraspanin CD37
impairs T-cell-dependent B-cell response under suboptimal costimulatory
conditions. Mol. Cell Biol. 20, 5363–5369. doi: 10.1128/MCB.20.15.5363-
5369.2000
Knol, E. F., Mul, F. P., Jansen, H., Calafat, J., and Roos, D. (1991). Monitoring
human basophil activation via CD63 monoclonal antibody 435. J. Allergy Clin.
Immunol. 88, 328–338. doi: 10.1016/0091-6749(91)90094-5
Köberle, M., Kaesler, S., Kempf, W., Wölbing, F., and Biedermann,
T. (2012). Tetraspanins in mast cells. Front. Immunol. 3:106. doi:
10.3389/fimmu.2012.00106
Kovárˇová, M., Tolar, P., Arudchandran, R., Dráberová, L., Rivera, J., and Dráber,
P. (2001). Structure-function analysis of Lyn kinase association with lipid rafts
and initiation of early signaling events after Fcε receptor I aggregation. Mol.
Cell Biol. 21, 8318–8328. doi: 10.1128/MCB.21.24.8318-8328.2001
Kraft, S., Fleming, T., Billingsley, J. M., Lin, S. Y., Jouvin, M. H., Storz, P., et al.
(2005). Anti-CD63 antibodies suppress IgE-dependent allergic reactions in
vitro and in vivo. J. Exp. Med. 201, 385–396. doi: 10.1084/jem.20042085
Kraft, S., Jouvin, M. H., Kulkarni, N., Kissing, S., Morgan, E. S., Dvorak, A.
M., et al. (2013). The tetraspanin CD63 is required for efficient IgE-mediated
mast cell degranulation and anaphylaxis. J. Immunol. 191, 2871–2878. doi:
10.4049/jimmunol.1202323
Lebduška, P., Korb, J., Tu˚mová, M., Heneberg, P., and Dráber, P. (2007).
Topography of signaling molecules as detected by electron microscopy on
plasma membrane sheets isolated from non-adherent mast cells. J. Immunol.
Methods 328, 139–151. doi: 10.1016/j.jim.2007.08.015
Lee, H., Bae, S., Jang, J., Choi, B. W., Park, C. S., Park, J. S., et al. (2013). CD53, a
suppressor of inflammatory cytokine production, is associated with population
asthma risk via the functional promoter polymorphism -1560 C>T. Biochim.
Biophys. Acta 1830, 3011–3018. doi: 10.1016/j.bbagen.2012.12.030
Le Naour, F., Rubinstein, E., Jasmin, C., Prenant, M., and Boucheix, C. (2000).
Severely reduced female fertility in CD9-deficient mice. Science 287, 319–321.
doi: 10.1126/science.287.5451.319
Levental, I., Lingwood, D., Grzybek, M., Coskun, U., and Simons, K. (2010).
Palmitoylation regulates raft affinity for the majority of integral raft proteins.
Proc. Natl. Acad. Sci. U.S.A. 107, 22050–22054. doi: 10.1073/pnas.1016184107
Ley, K., and Zhang, H. (2008). Dances with leukocytes: how tetraspanin-enriched
microdomains assemble to form endothelial adhesive platforms. J. Cell Biol.
183, 375–376. doi: 10.1083/jcb.200809173
Lillemeier, B. F., Mörtelmaier, M. A., Forstner, M. B., Huppa, J. B., Groves, J. T., and
Davis, M. M. (2016). TCR and Lat are expressed on separate protein islands on
T cell membranes and concatenate during activation. Nat. Immunol. 11, 90–96.
doi: 10.1038/ni.1832
Liu, Y., and Zhang, W. (2008). Identification of a new transmembrane adaptor
protein that constitutively binds Grb2 in B cells. J. Leukoc. Biol. 84, 842–851.
doi: 10.1189/jlb.0208087
Maecker, H. T., Do, M. S., and Levy, S. (1998). CD81 on B cells promotes
interleukin 4 secretion and antibody production during T helper type
2 immune responses. Proc. Natl. Acad. Sci. U.S.A. 95, 2458–2462. doi:
10.1073/pnas.95.5.2458
Maecker, H. T., and Levy, S. (1997). Normal lymphocyte development but delayed
humoral immune response in CD81-null mice. J. Exp. Med. 185, 1505–1510.
doi: 10.1084/jem.185.8.1505
Marshall, J. S. (2004). Mast-cell responses to pathogens. Nat. Rev. Immunol. 4,
787–799. doi: 10.1038/nri1460
McClatchey, A. I. (2014). ERM proteins at a glance. J. Cell Sci. 127, 3199–3204. doi:
10.1242/jcs.098343
McIntosh, A. L., Senthivinayagam, S., Moon, K. C., Gupta, S., Lwande, J. S.,
Murphy, C. C., et al. (2012). Direct interaction of Plin2 with lipids on the
surface of lipid droplets: a live cell FRET analysis. Am. J. Physiol Cell Physiol.
303, C728–C742. doi: 10.1152/ajpcell.00448.2011
Metz, M., Piliponsky, A. M., Chen, C. C., Lammel, V., Abrink, M., Pejler, G.,
et al. (2006). Mast cells can enhance resistance to snake and honeybee venoms.
Science 313, 526–530. doi: 10.1126/science.1128877
Miyado, K., Yamada, G., Yamada, S., Hasuwa, H., Nakamura, Y., Ryu, F., et al.
(2000). Requirement of CD9 on the egg plasma membrane for fertilization.
Science 287, 321–324. doi: 10.1126/science.287.5451.321
Ohtake, H., Ichikawa, N., Okada, M., and Yamashita, T. (2002). Cutting
Edge: Transmembrane phosphoprotein Csk-binding protein/phosphoprotein
associated with glycosphingolipid-enriched microdomains as a negative
feedback regulator of mast cell signaling through the FcεRI. J. Immunol. 168,
2087–2090. doi: 10.4049/jimmunol.168.5.2087
Otáhal, P., Angelisová, P., Hrdinka, M., Brdicˇka, T., Novák, P., Drbal, K.,
et al. (2010). A new type of membrane raft-like microdomains and their
possible involvement in TCR signaling. J. Immunol. 184, 3689–3696. doi:
10.4049/jimmunol.0902075
Owen, D. M., Williamson, D. J., Magenau, A., and Gaus, K. (2012). Sub-resolution
lipid domains exist in the plasma membrane and regulate protein diffusion and
distribution. Nat. Commun. doi: 10.1038/ncomms2273
Peng, L., Li, J. Z., Wu, H. Z., and Wang, M. J. (1997). The activation of human
platelets mediated by two monoclonal antibodies raised against CD9. Thromb.
Res. 87, 65–73. doi: 10.1016/S0049-3848(97)00105-9
Peng, W. M., Yu, C. F., Kolanus, W., Mazzocca, A., Bieber, T., Kraft, S., et al.
(2011). Tetraspanins CD9 and CD81 are molecular partners of trimeric FcεRI
on human antigen-presenting cells. Allergy 66, 605–611. doi: 10.1111/j.1398-
9995.2010.02524.x
Qi, J. C., Stevens, R. L., Wadley, R., Collins, A., Cooley, M., Naif, H. M., et al.
(2002). IL-16 regulation of human mast cells/basophils and their susceptibility
to HIV-1. J. Immunol. 168, 4127–4134. doi: 10.4049/jimmunol.168.8.4127
Qi, J. C., Wang, J., Mandadi, S., Tanaka, K., Roufogalis, B. D., Madigan, M. C., et al.
(2006). Human and mouse mast cells use the tetraspanin CD9 as an alternate
interleukin-16 receptor. Blood 107, 135–142. doi: 10.1182/blood-2005-03-1312
Frontiers in Cell and Developmental Biology | www.frontiersin.org 12 May 2016 | Volume 4 | Article 43
Halova and Draber Tetraspanins/TRAPs As Plasma Membrane Organizers
Resh, M. D. (1999). Fatty acylation of proteins: new insights into membrane
targeting of myristoylated and palmitoylated proteins. Biochim .Biophys. Acta.
1451, 1–16. doi: 10.1016/S0167-4889(99)00075-0
Risinger, J. I., Custer, M., Feigenbaum, L., Simpson, R. M., Hoover, S. B., Webster,
J. D., et al. (2014). Normal viability of Kai1/CD82 deficient mice.Mol. Carcinog.
53, 610–624. doi: 10.1002/mc.22009
Rivera, J. (2002). Molecular adapters in FcεRI signaling and the allergic response.
Curr. Opin. Immunol. 14, 688–693. doi: 10.1016/S0952-7915(02)00396-5
Rivera, J. (2005). NTAL/LAB and LAT: a balancing act in mast-cell activation and
function. Trends Immunol. 26, 119–122. doi: 10.1016/j.it.2005.01.001
Rouquette-Jazdanian, A. K., Kortum, R. L., Li, W., Merrill, R. K., Nguyen, P.
H., Samelson, L. E., et al. (2015). miR-155 controls lymphoproliferation
in LAT mutant mice by restraining T-cell apoptosis via SHIP-1/mTOR
and PAK1/FOXO3/BIM pathways. PLoS ONE 10:e0131823. doi:
10.1371/journal.pone.0131823
Rubinstein, E., Ziyyat, A., Prenant, M.,Wrobel, E., Wolf, J. P., Levy, S., et al. (2006).
Reduced fertility of female mice lacking CD81. Dev. Biol. 290, 351–358. doi:
10.1016/j.ydbio.2005.11.031
Rust, M. J., Bates, M., and Zhuang, X. (2006). Sub-diffraction-limit imaging
by stochastic optical reconstruction microscopy (STORM). Nat. Methods 3,
793–795. doi: 10.1038/nmeth929
Sachs, N., Kreft, M., van den Bergh Weerman, M. A., Beynon, A. J., Peters, T.
A., Weening, J. J., et al. (2006). Kidney failure in mice lacking the tetraspanin
CD151. J. Cell Biol. 175, 33–39. doi: 10.1083/jcb.200603073
Saitoh, S., Arudchandran, R., Manetz, T. S., Zhang,W., Sommers, C. L., Love, P. E.,
et al. (2000). LAT is essential for FcεRI-mediatedmast cell activation. Immunity.
12, 525–535. doi: 10.1016/S1074-7613(00)80204-6
Sala-Valdés, M., Ursa, A., Charrin, S., Rubinstein, E., Hemler, M. E., Sánchez-
Madrid, F., et al. (2006). EWI-2 and EWI-F link the tetraspanin web to the
actin cytoskeleton through their direct association with ezrin-radixin-moesin
proteins. J. Biol. Chem. 281, 19665–19675. doi: 10.1074/jbc.M602116200
Schäfer, T., Starkl, P., Allard, C., Wolf, R. M., and Schweighoffer, T. (2010).
A granular variant of CD63 is a regulator of repeated human mast cell
degranulation. Allergy 65, 1242–1255. doi: 10.1111/j.1398-9995.2010.02350.x
Schröder, J., Lüllmann-Rauch, R., Himmerkus, N., Pleines, I., Nieswandt, B.,
Orinska, Z., et al. (2009). Deficiency of the tetraspanin CD63 associated with
kidney pathology but normal lysosomal function.Mol. Cell Biol. 29, 1083–1094.
doi: 10.1128/MCB.01163-08
Sheets, E. D., Holowka, D., and Baird, B. (1999). Critical role for cholesterol
in Lyn-mediated tyrosine phosphorylation of FcεRI and their association
with detergent-resistant membranes. J. Cell Biol. 145, 877–887. doi:
10.1083/jcb.145.4.877
Shelby, S. A., Holowka, D., Baird, B., and Veatch, S. L. (2013). Distinct
stages of stimulated FcεRI receptor clustering and immobilization are
identified through superresolution imaging. Biophys. J. 105, 2343–2354. doi:
10.1016/j.bpj.2013.09.049
Sherman, E., Barr, V., Manley, S., Patterson, G., Balagopalan, L., Akpan,
I., et al. (2011). Functional nanoscale organization of signaling molecules
downstream of the T cell antigen receptor. Immunity 35, 705–720. doi:
10.1016/j.immuni.2011.10.004
Simons, K., and Gerl, M. J. (2010). Revitalizing membrane rafts: new tools and
insights. Nat. Rev. Mol. Cell Biol. 11, 688–699. doi: 10.1038/nrm2977
Simons, K., and Ikonen, E. (1997). Functional rafts in cell membranes. Nature 387,
569–572. doi: 10.1038/42408
Simons, K., and Sampaio, J. L. (2011). Membrane organization and lipid rafts. Cold
Spring Harb. Perspect. Biol. 3:a004697. doi: 10.1101/cshperspect.a004697
Singer, S. J., and Nicolson, G. L. (1972). The fluid mosaic model of the structure of
cell membranes. Science 175, 720–731. doi: 10.1126/science.175.4023.720
Stepanek, O., Draber, P., and Horejsi, V. (2014). Palmitoylated transmembrane
adaptor proteins in leukocyte signaling. Cell Signal. 26, 895–902. doi:
10.1016/j.cellsig.2014.01.007
Surviladze, Z., Dráberová, L., Kovárˇová, M., Boubelík, M., and Dráber, P. (2001).
Differential sensitivity to acute cholesterol lowering of activation mediated via
the high-affinity IgE receptor and Thy-1 glycoprotein. Eur. J. Immunol.
31, 1–10. doi: 10.1002/1521-4141(200101)31:1<1::AID-IMMU1>3.0.
CO;2-W
Takeda, Y., Kazarov, A. R., Butterfield, C. E., Hopkins, B. D., Benjamin, L. E.,
Kaipainen, A., et al. (2007). Deletion of tetraspanin Cd151 results in decreased
pathologic angiogenesis in vivo and in vitro. Blood 109, 1524–1532. doi:
10.1182/blood-2006-08-041970
Tarrant, J. M., Robb, L., van Spriel, A. B., and Wright, M. D. (2003). Tetraspanins:
molecular organisers of the leukocyte surface. Trends Immunol. 24, 610–617.
doi: 10.1016/j.it.2003.09.011
Todeschini, A. R., Dos Santos, J. N., Handa, K., and Hakomori, S. I. (2007).
Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-
talk with integrins, providing a basis for control of cell motility through
glycosynapse. J. Biol. Chem. 282, 8123–8133. doi: 10.1074/jbc.M611407200
Treanor, B., and Batista, F. D. (2010). Organisation and dynamics of antigen
receptors: implications for lymphocyte signalling. Curr. Opin. Immunol. 22,
299–307. doi: 10.1016/j.coi.2010.03.009
Tumová, M., Koffer, A., Šimícˇek, M., Dráberová, L., and Dráber, P. (2010). The
transmembrane adaptor protein NTAL signals to mast cell cytoskeleton via the
small GTPase Rho. Eur. J. Immunol. 40, 3235–3245. doi: 10.1002/eji.201040403
Valent, P., Schernthaner, G. H., Sperr, W. R., Fritsch, G., Agis, H., Willheim,
M., et al. (2001). Variable expression of activation-linked surface antigens
on human mast cells in health and disease. Immunol. Rev. 179, 74–81. doi:
10.1034/j.1600-065X.2001.790108.x
van Meer, G., Voelker, D. R., and Feigenson, G. W. (2008). Membrane lipids:
where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112–124. doi:
10.1038/nrm2330
van Zelm, M. C., Smet, J., Adams, B., Mascart, F., Schandene, L., Janssen,
F., et al. (2010). CD81 gene defect in humans disrupts CD19 complex
formation and leads to antibody deficiency. J. Clin. Invest 120, 1265–1274. doi:
10.1172/JCI39748
Veatch, S. L., Chiang, E. N., Sengupta, P., Holowka, D. A., and Baird, B. A. (2012).
Quantitative nanoscale analysis of IgE-FcεRI clustering and coupling to early
signaling proteins. J. Phys. Chem. B 116, 6923–6935. doi: 10.1021/jp300197p
Volná, P., Lebduška, P., Dráberová, L., Šímová, S., Heneberg, P., Boubelík, M., et al.
(2004). Negative regulation of mast cell signaling and function by the adaptor
LAB/NTAL. J. Exp. Med. 200, 1001–1013. doi: 10.1084/jem.20041213
Wang, Y., Horvath, O., Hamm-Baarke, A., Richelme,M., Gregoire, C., Guinamard,
R., et al. (2005). Single and combined deletions of the NTAL/LAB and LAT
adaptors minimally affect B-cell development and function. Mol. Cell Biol. 25,
4455–4465. doi: 10.1128/MCB.25.11.4455-4465.2005
Williamson, D. J., Owen, D. M., Rossy, J., Magenau, A., Wehrmann, M., Gooding,
J. J., et al. (2011). Pre-existing clusters of the adaptor Lat do not participate in
early T cell signaling events. Nat. Immunol. 12, 655–662. doi: 10.1038/ni.2049
Wilson, B. S., Pfeiffer, J. R., and Oliver, J. M. (2002). FcεRI signaling observed
from the inside of the mast cell membrane.Mol. Immunol. 38, 1259–1268. doi:
10.1016/S0161-5890(02)00073-1
Wilson, B. S., Pfeiffer, J. R., Surviladze, Z., Gaudet, E. A., and Oliver, J. M.
(2001). High resolution mapping of mast cell membranes reveals primary
and secondary domains of FcεRI and LAT. J. Cell Biol. 154, 645–658. doi:
10.1083/jcb.200104049
Wright, M. D., Geary, S.M., Fitter, S., Moseley, G.W., Lau, L.M., Sheng, K. C., et al.
(2004). Characterization of mice lacking the tetraspanin superfamily member
CD151.Mol. Cell Biol. 24, 5978–5988. doi: 10.1128/MCB.24.13.5978-5988.2004
Xavier, R., Brennan, T., Li, Q., McCormack, C., and Seed, B. (1998). Membrane
compartmentation is required for efficient T cell activation. Immunity 8,
723–732. doi: 10.1016/S1074-7613(00)80577-4
Yang, X., Claas, C., Kraeft, S. K., Chen, L. B., Wang, Z., Kreidberg, J. A., et al.
(2002). Palmitoylation of tetraspanin proteins: modulation of CD151 lateral
interactions, subcellular distribution, and integrin-dependent cell morphology.
Mol. Biol. Cell 13, 767–781. doi: 10.1091/mbc.01-05-0275
Yang, X., Kovalenko, O. V., Tang, W., Claas, C., Stipp, C. S., and Hemler,
M. E. (2004). Palmitoylation supports assembly and function of integrin-
tetraspanin complexes. J. Cell Biol. 167, 1231–1240. doi: 10.1083/jcb.2004
04100
Zemni, R., Bienvenu, T., Vinet, M. C., Sefiani, A., Carrié, A., Billuart, P., et al.
(2000). A new gene involved in X-linked mental retardation identified by
analysis of an X;2 balanced translocation. Nat. Genet. 24, 167–170. doi:
10.1038/72829
Zhang, J., Fei, B., Wang, Q., Song, M., Yin, Y., Zhang, B., et al. (2014). MicroRNA-
638 inhibits cell proliferation, invasion and regulates cell cycle by targeting
tetraspanin 1 in human colorectal carcinoma. Oncotarget 5, 12083–12096. doi:
10.18632/oncotarget.2499
Frontiers in Cell and Developmental Biology | www.frontiersin.org 13 May 2016 | Volume 4 | Article 43
Halova and Draber Tetraspanins/TRAPs As Plasma Membrane Organizers
Zhang, W., Sommers, C. L., Burshtyn, D. N., Stebbins, C. C., DeJarnette, J. B.,
Trible, R. P., et al. (1999). Essential role of LAT in T cell development. Immunity
10, 323–332. doi: 10.1016/S1074-7613(00)80032-1
Zhang, W., Trible, R. P., and Samelson, L. E. (1998). LAT palmitoylation:
its essential role in membrane microdomain targeting and tyrosine
phosphorylation during T cell activation. Immunity 9, 239–246. doi:
10.1016/S1074-7613(00)80606-8
Zhu, M., Granillo, O., Wen, R., Yang, K., Dai, X., Wang, D., et al. (2005a). Negative
regulation of lymphocyte activation by the adaptor protein LAX. J. Immunol.
174, 5612–5619. doi: 10.4049/jimmunol.174.9.5612
Zhu, M., Janssen, E., Leung, K., and Zhang, W. (2002). Molecular cloning of
a novel gene encoding a membrane-associated adaptor protein (LAX) in
lymphocyte signaling. J. Biol. Chem. 277, 46151–46158. doi: 10.1074/jbc.M2089
46200
Zhu, M., Liu, Y., Koonpaew, S., Granillo, O., and Zhang, W. (2004).
Positive and negative regulation of FcεRI-mediated signaling by the adaptor
protein LAB/NTAL. J. Exp. Med. 200, 991–1000. doi: 10.1084/jem.200
41223
Zhu, M., Rhee, I., Liu, Y., and Zhang, W. (2006). Negative regulation of FcεRI-
mediated signaling and mast cell function by the adaptor protein LAX. J. Biol.
Chem. 281, 18408–18413. doi: 10.1074/jbc.M601535200
Zhu, M., Shen, S., Liu, Y., Granillo, O., and Zhang, W. (2005b). Cutting
edge: localization of linker for activation of T cells to lipid rafts is not
essential in T cell activation and development. J. Immunol. 174, 31–35. doi:
10.4049/jimmunol.174.1.31
Zöller, M. (2009). Tetraspanins: push and pull in suppressing and promoting
metastasis. Nat. Rev. Cancer 9, 40–55. doi: 10.1038/nrc2543
Zuidscherwoude, M., Göttfert, F., Dunlock, V. M., Figdor, C. G., van den
Bogaart, G., and van Spriel, A. B. (2015). The tetraspanin web revisited
by super-resolution microscopy. Sci. Rep. 5, 12201. doi: 10.1038/srep
12201
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Halova and Draber. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 14 May 2016 | Volume 4 | Article 43
